Newsroom

Here you will find news and press releases of the DZIF as well as our media centre.

Image featuring the logos of Qubigen, DZIF, and IMC on a blue background with stylized microbes and viruses

Jun 2 2026

Launch of a joint project with Qubigen to develop antiviral drugs using federated AI

Press Office

If you have any questions about DZIF or specific press releases, you have come to the right place. We will also gladly put you on to the experts in each specific field. Please get in touch with us.

Dr. Nicola Wittekindt

Public Relations Officer

Martina Lienhop

Public Relations Officer

Janna Schmidt

Public Relations Officer

Send mail

A cloved hand is taking a swab sample from the tongue in an open mouth

May 28 2026

A single swab is all it takes: Study paves the way for easier tuberculosis detection

An international research team led by scientists from Heidelberg University’s Faculty of Medicine and the University of California, San Francisco (USA), has investigated a new method for diagnosing

European Vaccines Hub Annual Meeting 2026

May 27 2026

European Vaccines Hub for Pandemic Readiness marks one year of progress

The European Vaccines Hub (EVH) for Pandemic Readiness convened its annual consortium meeting at the Old University of the Marburg University, in Marburg, Germany, from May 19 to 21, 2026. The EVH is

May 26 2026

US Food and Drug Administration (FDA) approves hepatitis drug Hepcludex (bulevirtide)

With the FDA approval of Hepcludex (bulevirtide), a therapy for chronic hepatitis D developed at the Heidelberg Faculty of Medicine at Heidelberg University, Heidelberg University Hospital, and the

All news

Find Media Content

Press Office

Always up-to-date

Follow us on: